Bedtime Doses of Prazosin Do Not Affect Daytime Salivary Amylase Markers in PTSD

Heliyon - Netherlands
doi 10.1016/j.heliyon.2019.e01709
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Prazosin for the Treatment of PTSD

Current Treatment Options in Psychiatry
PsychiatryClinical PsychologyMental Health
2015English

Single Therapeutic and Supratherapeutic Doses of Sacubitril/Valsartan (LCZ696) Do Not Affect Cardiac Repolarization

European Journal of Clinical Pharmacology
MedicinePharmacology
2016English

Daytime Changes of Salivary Biomarkers Involved in Pain

Journal of Oral Rehabilitation
Dentistry
2020English

Prazosin for Treatment of Patients With PTSD and Comorbid Alcohol Dependence

2011English

Effect of Fluoride Solution on Salivary Amylase Activity

Jurnal Ilmiah Kedokteran Wijaya Kusuma
2017English

Single Therapeutic and Supra‐Therapeutic Doses of Ubrogepant Do Not Affect Cardiac Repolarization in Healthy Adults: Results From a Randomized Trial

Clinical Pharmacology and Therapeutics
Pharmacology
2019English

Altered Salivary Amylase Gene in the Mouse Strain BXD-16

Heredity
Genetics
1982English

Physiological Concentrations of Leptin Do Not Affect Human Neutrophils

PLoS ONE
Multidisciplinary
2013English

Responses of Salivary Cortisol and Α-Amylase to Official Competition

Journal of Human Sport and Exercise
Physical TherapySports TherapyRehabilitationSports Science
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy